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Abstract
Usually differentiated thyroid cancer is a slow growing tumor with low metastatic potential. We present the case of female patient 
of 26-years-old who underwent thyroidectomy, followed by 3.7 GBq of 131 I. The post-therapeutic whole-body scan showed 
intense uptake in the left part of posterior thorax and a faint radioactivity in the upper right tibia. A Chest CT-scan and a locali-
zed knee MRI confirm that they are bone metastasis in the middle portion of the 8th right rib and in the upper tibial metaphysic.
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Background
The incidence of distant metastasis is lower in case of papillary 
carcinoma (3.5–3.8% of cases) [1]. The most common site of distant 
metastases is the lung, followed by the bone [2].
Case report
This 26-year-old patient had no significant medical history. She 
had undergone a total thyroidectomy without regional lymph node 
dissection. Histological examination revealed a multifocal follicular 
variant of papillary carcinoma, well-differentiated. The TNM clas-
sification was pT1bmNxMx.
Four weeks later she received, with thyroid hormone withdrawal, 
3.7 GBq of 131 I as a treatment; no symptoms ensued. At this time, 
the serum thyroglobulin level was 273 ng/mL, TSH was 32.8 µIU/ml 
and antithyroglobulin antibody level was less than 20 IU/mL.
The post-therapeutic whole-body scan (Figure 1) showed 
intense uptake in the left part of posterior thorax and a faint radioac-
tivity in the upper right tibia. A whole-body bone scanning was per-
formed and matched with whole body iodine scan (Figure 2). The 
intense uptake was localized exactly inside of a photopenic focus on 
the middle portion of the 8th right rib. Chest CT-scan (Figure 3) 
revealed an osteolytic lesion in this focus. A localized knee MRI 
(Figures 4 and 5) was done showing a T1 low signal intensity with 
bright T2 signal in the upper tibial metaphysic.
Figure 1. A post-3.7 GBq of 131 I whole-body scan showing 2 uptake 
in the left part of posterior thorax and in the upper right tibia
The patient underwent a resection of the middle portion of 
the 8th right rib. Pathological examination (Figure 6) confirm that it 
was a metastasis of thyroid carcinoma.





Only about 20% of patients with DTC show a metastatic evolu-
tion [3]. The bone metastasis represent only 9% of patients [3]. In 
50–80% of cases, there are multiple bone metastases [4].
According to different studies, bone metastases are more 
common in patients with follicular carcinomas (15.2–33.7%) than 
in those with papillary carcinomas (0.6–6.9%) [5]. Distant bone 
metastases are rare in patients with differentiated thyroid malig-
nancy with the sternum, ribs, and spine being the most frequent 
sites of osseous metastases [6]. In our case, the patient present 
an uncommon association of rib and tibial metastasis.
Figure 2. A matching of a wholebody bone scanning and a whole 
body iodine scan showing that the intense uptake was localized 
exactly inside of a photopenic focus on the the middle portion of the 
8th right rib
Figure 3. CT scan revealed an osteolytic lesion in the the middle 
portion of the 8th right rib
Figure 4. A knee MRI showing a bright T2 signal in the upper tibial 
metaphysic
Figure 5. A knee MRI showing a T1 low signal intensity in the upper 
tibial metaphysic
Figure 6. Histological examination confirm that it was a mestastasis of 
thyroid carcinoma
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